Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SmithKline Beecham claims indolines for CNS disorders

March 11, 1998

FDA Advisory Committee will meet to discuss Myotrophin

March 11, 1998

New antimigraine candidates described by Allelix

March 10, 1998

Forbes Medi-Tech files patent application covering AD prevention

March 6, 1998

Xanthene derivatives useful for neurodegenerative disorders

March 6, 1998

Provigil launched in U.K.

March 5, 1998

Parkinson's disease drug approved in Europe

March 5, 1998

Nippon Kayaku and Signal to develop peripheral neuropathy drugs

March 5, 1998

A new therapeutic target for AD: bleomycin hydrolase

March 5, 1998

NIH researchers discover how light shuts off melatonin production

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...